Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunologic Markers”

145 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 145 results

Not applicableStudy completedNCT00026676
What this trial is testing

Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With Didanosine

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 82
Not applicableUnknownNCT05699785
What this trial is testing

Comparison of Inflammatory Markers and Incidence of Comorbidities in Patients on Antiretroviral Therapy With Second-generation Anti-integrase Drugs on Triple Versus Dual Therapy

Who this might be right for
Hiv
Centre Hospitalier Universitaire de Nice 500
Not applicableStudy completedNCT05369156
What this trial is testing

The Effects of Chiropractic Care in Adults With Subclinical Spinal Pain

Who this might be right for
Subclinical Spinal Pain
Riphah International University 120
Testing effectiveness (Phase 2)Study completedNCT01974245
What this trial is testing

Supplementation With Cholecalciferol in Dialysis Patients

Who this might be right for
Chronic Kidney Disease
Federal University of São Paulo 55
Not applicableStudy completedNCT01129128
What this trial is testing

Three Arm Trial of Immune Effects of Echinacea

Who this might be right for
Upper Respiratory Tract Infections
University of Washington 67
Testing effectiveness (Phase 2)Ended earlyNCT00104429
What this trial is testing

GW873140 In Combination With Combivir In HIV Infected Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 125
Not applicableUnknownNCT00167700
What this trial is testing

Pre-, Peri- and Postnatal Programming and Origins of Disease: Early Targeting the Epidemics of Allergy and Overweight

Who this might be right for
Allergic DiseaseObesityImmunology
University of Turku 800
Post-approval studies (Phase 4)Study completedNCT02234492
What this trial is testing

The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients

Who this might be right for
Human Immunodeficiency Virus (HIV)Cardiovascular Disease (CVD)
Ottawa Heart Institute Research Corporation 35
Not applicableStudy completedNCT02675348
What this trial is testing

Beef Protein Supplementation in Endurance Athletes

Who this might be right for
Dietary Modification
University of Greenwich 24
Not applicableUnknownNCT02005094
What this trial is testing

The Role of Inflammasome in Inflammatory Macrophage in Mycobacterium Avium Complex-lung Disease and Mycobacterium Abscessus-lung Disease

Who this might be right for
To Investigate the Inflammasome Response of Inflammatory and Resting MacrophageTo Compare the Difference of Inflammasome Response of Inflammatory MacrophageTo Study the Diagnostic Aid From Immunological Markers in Inflammasome Response
National Taiwan University Hospital 100
Not applicableUnknownNCT03563482
What this trial is testing

Correlation of Metabolic Imaging With Immune Markers in NSCLC Candidate to Immunotherapy.

Who this might be right for
Carcinoma, Non-Small-Cell LungPositron-Emission TomographyImmunotherapy
Istituto Clinico Humanitas 500
Early research (Phase 1)UnknownNCT00005120
What this trial is testing

The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Sarawak MediChem Pharmaceuticals 16
Not applicableUnknownNCT03941210
What this trial is testing

Micro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected Patients

Who this might be right for
HIV InfectionTuberculosis Infection
ANRS, Emerging Infectious Diseases 134
Not applicableStudy completedNCT02410603
What this trial is testing

Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer

Who this might be right for
Lung CancerLung NeoplasmsCancer of Lung+8 more
Mayo Clinic 64
Not applicableLooking for participantsNCT07477925
What this trial is testing

Immunological and Virological Prognostic Markers of Human Cytomegalovirus (HCMV) Congenital Infection in Pregnant Women With Primary HCMV Infection.

Who this might be right for
Human Cytomegalovirus (HCMV)
Fondazione IRCCS Policlinico San Matteo di Pavia 90
Not applicableStudy completedNCT01177124
What this trial is testing

Mindfulness-Based Stress Reduction (MBSR) Symptom Cluster Trial for Breast Cancer Survivors

Who this might be right for
Breast Cancer
Cecile Lengacher 300
Testing effectiveness (Phase 2)Study completedNCT06390748
What this trial is testing

Esmolol in Sepsis Management:Evaluating Immunomodulatory Effects and Impact on Patient Outcomes

Who this might be right for
SepsisLymphocyte Disorder TImmunologic Paralysis+4 more
Lin Chen 150
Testing effectiveness (Phase 2)Study completedNCT01969058
What this trial is testing

Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 76
Not applicableUnknownNCT02193685
What this trial is testing

Identification Genetic, Immunologic and Microbial Markers of Hirschsprung Associated Enterocolitis in Children With Hirschsprung Disease

Who this might be right for
Hirschsprung DiseaseEnterocolitis
Cedars-Sinai Medical Center 400
Not applicableStudy completedNCT00107029
What this trial is testing

Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth

Who this might be right for
HIV Infection
University of North Carolina, Chapel Hill 113
Load More Results